Cassava's Alzheimer's drug appears backed by strong data and plenty of public support. That's a winning combination for SAVA stock. More
Articles
Novavax Is a Much Better Growth Buy Than Moderna Here
NVAX benefits from several near-term catalysts that will push the stock higher, making it a better buy than more mature enterprises. More
Cassava Sciences’ Stock Remains an Enigma
Cassava Sciences has lost 26% for the month through Oct. 27. Entering October, SAVA stock looked to go on a big run. It did the opposite. More
ContextLogic’s Reputation Could Come Back to Bite It
With the pandemic causing a massive supply chain disruption, the reputation of WISH stock may come back and bite it. More
Vinco Ventures May Be a Buy as the Redditors Appear to Be Packing It In
Continue to view BBIG stock with a critical eye. But keep it on your radar, as more information and a lower stock price could make it worthwhile buy. More
Politics Alone Isn’t Going To Stoke Gains in Pot-stock Sundial Growers
Although the political backdrop seems very favorable for SNDL stock, the reality could be that no one wants to touch this hot potato. More
